Get started
Author

Danny R. van Weelij

Observed names: Danny R. Weelij, Danny van Weelij
ORCID: 0009-0002-3842-3861
Observed ORCID: 0009-0002-3842-3861
OpenAlex ID: A5119496763
Characterization of murine MGL1 and MGL2 C-type lectins: Distinct glycan specificities and tumor binding properties
2009 · Satwinder Kaur Singh, Ingeborg Streng-Ouwehand, et al. · Molecular Immunology · 100
Recruiting and Consenting Decentralized Clinical Trial Participants—Learnings from the Trials@Home RADIAL Proof‐of‐Concept Trial
2025 · Bart Lagerwaard, Linda Rutgrink, et al. · Clinical Pharmacology & Therapeutics · 12
PDF
Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials
2025 · Mira G.P. Zuidgeest, Megan Heath, et al. · Clinical Pharmacology & Therapeutics · 10
PDF
Selecting and Preparing Clinical Sites for the Successful Conduct of Decentralized Clinical Trial Activities–Findings From the Trials@Home RADIAL Proof‐of‐Concept Trial
2025 · Katarzyna Lipinska, Danny van Weelij, et al. · Clinical Pharmacology & Therapeutics · 8
PDF
The Supply of Investigational Medicinal Product and Management of Study Materials for Decentralized Participants—Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial
2025 · Megan Heath, Amos J. de Jong, et al. · Clinical Pharmacology & Therapeutics · 4
PDF
Works count: 5
Citation count: 134
H-index: 4
I10-index: 3
Year
Topic
Type